Hyaluronidase enzyme formulations for high volume administration
US12178860B2 · kind B2 · utility
0Cited by
34References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 2023 |
| Grant date | Dec 31, 2024 |
| Priority date | — |
| Expiry date | Dec 22, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y302/01035
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, the present disclosure provides a formulation comprising a hyaluronidase enzyme and a therapeutically effective amount of an active ingredient. In another aspect, the present disclosure provides a method of administering a high volume of the formulation in a single administration to treat a disease or disorder in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.